ADAPTIMMUNE THERAPEUTICS PLC
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2016 | — | -576.6% | -533.8% |
| Jun 2016 | — | -6,920.7% | -6,736.3% |
| Sep 2016 | — | -770.6% | -765.5% |
| Dec 2016 | — | -171.7% | -180.6% |
| Mar 2017 | — | -777.8% | -762.4% |
| Jun 2017 | — | -675.4% | -574.1% |
| Sep 2017 | — | -18.2% | -3.2% |
| Dec 2017 | — | -695.6% | -638.5% |
| Mar 2018 | — | -350.7% | -253.0% |
| Jun 2018 | — | -319.5% | -485.1% |
| Sep 2018 | — | 17.2% | 12.9% |
| Dec 2018 | — | -2,147.8% | -2,445.8% |
| Jun 2019 | — | -22,612.7% | -26,170.1% |
| Sep 2019 | — | -16,928.7% | -16,583.1% |
| Dec 2019 | — | -4,169.6% | -4,033.5% |
| Mar 2020 | — | -3,911.2% | -3,701.3% |
| Jun 2020 | — | -6,026.5% | -5,952.2% |
| Sep 2020 | — | -3,007.1% | -2,970.0% |
| Dec 2020 | — | -2,497.5% | -2,437.6% |
| Mar 2021 | — | -8,730.2% | -8,701.2% |
| Jun 2021 | — | -1,270.2% | -1,262.3% |
| Sep 2021 | — | -3,506.3% | -3,524.6% |
| Dec 2021 | — | -3,025.0% | -2,742.3% |
| Mar 2022 | — | -1,398.1% | -1,406.0% |
| Jun 2022 | — | -790.0% | -803.9% |
| Sep 2022 | — | -613.5% | -591.1% |
| Dec 2022 | — | -247.0% | -265.2% |
| Mar 2023 | — | 3.5% | 2.2% |
| Jun 2023 | — | -875.4% | -416.9% |
| Sep 2023 | — | -637.1% | -623.0% |
| Dec 2023 | — | -21,582.7% | -20,743.3% |
| Mar 2024 | — | -867.6% | -854.2% |
| Jun 2024 | — | 53.6% | 54.2% |
| Sep 2024 | — | -35.9% | -43.1% |
| Dec 2024 | — | -2,281.8% | -2,303.4% |
| Mar 2025 | 87.9% | -627.8% | -653.2% |
| Jun 2025 | 81.7% | -221.5% | -221.8% |